Precigen Inc (NASDAQ:PGEN) price on Thursday, April 10, fall -7.91% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.28.
A look at the stock’s price movement, the close in the last trading session was $1.39, moving within a range at $1.25 and $1.35. The beta value (5-Year monthly) was 1.695. Turning to its 52-week performance, $2.17 and $0.65 were the 52-week high and 52-week low respectively. Overall, PGEN moved -28.09% over the past month.
Precigen Inc’s market cap currently stands at around $376.38 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-18.
The average forecast suggests down to a -53.05% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 11.07M, representing a 182.16% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PGEN is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend PGEN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PGEN’s current price about -17.88% and -23.33% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 39.14, while 7-day volatility ratio is 17.91% and 10.24% in the 30-day chart. Further, Precigen Inc (PGEN) has a beta value of 1.83, and an average true range (ATR) of 0.16. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -368.75% off current price level while to achieve the yearly target high, price needs to move -368.75%. Nonetheless, investors will most likely welcome a -368.75% jump to $6 which is the analysts’ median price.
If we refocus on Precigen Inc (NASDAQ:PGEN), historical trading data shows that trading volumes averaged 1.62 over the past 10 days and 1.77 million over the past 3 months. The company’s latest data on shares outstanding shows there are 292.87 million shares.
The 44.77% of Precigen Inc’s shares are in the hands of company insiders while institutional holders own 25.74% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 22.66 million on 2025-03-14, giving us a short ratio of 12.62. The data shows that as of 2025-03-14 short interest in Precigen Inc (PGEN) stood at 1173.0 of shares outstanding, with shares short rising to 19.05 million registered in 2025-02-14. Current price change has pushed the stock 14.29% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PGEN stock continues to rise going into the next quarter.
